Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04310397
What this trial is testing

Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma

Who this might be right for
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT05161572
What this trial is testing

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

Who this might be right for
Stomach NeoplasmsEsophagogastric Junction DisorderNeoadjuvant Therapy+5 more
Fudan University 6
Not applicableLooking for participantsNCT05595408
What this trial is testing

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

Who this might be right for
Muscle Invasive Upper Tract Urothelial Carcinoma
RenJi Hospital 84
Testing effectiveness (Phase 2)Ended earlyNCT00929019
What this trial is testing

Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Who this might be right for
Uveal Melanoma
Radboud University Medical Center 23
Testing effectiveness (Phase 2)Looking for participantsNCT07120698
What this trial is testing

Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)MRDII-IIIB Stages+1 more
Guangdong Association of Clinical Trials 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT06490107
What this trial is testing

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

Who this might be right for
Biliary Tract Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Ended earlyNCT03050554
What this trial is testing

SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Early Stage Non-Small Cell Lung Cancer
Andrew Sharabi 2
Early research (Phase 1)Ended earlyNCT00455572
What this trial is testing

Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 71
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT02451982
What this trial is testing

Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 76
Not applicableEnded earlyNCT04516122
What this trial is testing

Bone Loss in Melanoma Survivors Receiving Immunotherapy

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage III Cutaneous Melanoma AJCC v8+5 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT02772094
What this trial is testing

Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)

Who this might be right for
Glioblastoma MultiformeGlioblastoma
China Medical University Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT07140679
What this trial is testing

Immunotherapy (Toripalimab) for Reducing Recurrence Risk After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer

Who this might be right for
Localized Colon CarcinomaStage IIB Colon Cancer AJCC v8Stage IIC Colon Cancer AJCC v8+1 more
Emory University 40
Testing effectiveness (Phase 2)UnknownNCT03443856
What this trial is testing

Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence

Who this might be right for
Gastric and Esophagogastric Junction Adenocarcinoma
European Organisation for Research and Treatment of Cancer - EORTC 197
Not applicableUnknownNCT06009705
What this trial is testing

Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer

Who this might be right for
Esophageal Carcinoma
Hebei Medical University Fourth Hospital 56
Testing effectiveness (Phase 2)Study completedNCT07671495
What this trial is testing

Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin

Who this might be right for
Melanoma Stage IMelanoma Stage IIIMelanoma Stage II+1 more
MIPO Clinic 278
Testing effectiveness (Phase 2)UnknownNCT05844371
What this trial is testing

Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery

Who this might be right for
Gastric Cancer
Yixing People's Hospital 60
Early research (Phase 1)Study completedNCT02549833
What this trial is testing

Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma

Who this might be right for
OligodendrogliomaAstrocytoma, Grade IIGlioma, Astrocytic+3 more
Jennie Taylor 28
Large-scale testing (Phase 3)UnknownNCT04277221
What this trial is testing

ADCTA for Adjuvant Immunotherapy in Standard Treatment of Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Safe Save Medical Cell Sciences & Technology Co.,Ltd. 118
Testing effectiveness (Phase 2)WithdrawnNCT06116578
What this trial is testing

Study Evaluating Pembrolizumab +/- Olaparib in TLS Positive Selected Resectable STS Followed by Adjuvant Pembrolizumab

Who this might be right for
Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Next Page